D.E. Shaw & Co’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,107
| Closed | -$61.8K | – | 3161 |
|
|
2024
Q4 | $61.8K | Sell |
10,107
-87,609
| -90% | -$535K | ﹤0.01% | 2829 |
|
|
2024
Q3 | $1.62M | Sell |
97,716
-33,349
| -25% | -$552K | ﹤0.01% | 1915 |
|
|
2024
Q2 | $900K | Buy |
131,065
+37,902
| +41% | +$260K | ﹤0.01% | 2217 |
|
|
2024
Q1 | $899K | Buy |
93,163
+45,918
| +97% | +$443K | ﹤0.01% | 2152 |
|
|
2023
Q4 | $393K | Sell |
47,245
-28,669
| -38% | -$238K | ﹤0.01% | 2462 |
|
|
2023
Q3 | $634K | Sell |
75,914
-99,672
| -57% | -$832K | ﹤0.01% | 2240 |
|
|
2023
Q2 | $1.62M | Sell |
175,586
-148,951
| -46% | -$1.37M | ﹤0.01% | 1851 |
|
|
2023
Q1 | $4.46M | Sell |
324,537
-65,349
| -17% | -$898K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $6.63M | Buy |
389,886
+52,716
| +16% | +$897K | 0.01% | 1269 |
|
|
2022
Q3 | $7.67M | Buy |
337,170
+62,616
| +23% | +$1.42M | 0.01% | 1084 |
|
|
2022
Q2 | $4.95M | Sell |
274,554
-111,158
| -29% | -$2M | 0.01% | 1564 |
|
|
2022
Q1 | $10.3M | Buy |
385,712
+253,614
| +192% | +$6.78M | 0.01% | 1081 |
|
|
2021
Q4 | $3.87M | Buy |
132,098
+116,413
| +742% | +$3.41M | ﹤0.01% | 1894 |
|
|
2021
Q3 | $1.03M | Sell |
15,685
-11,675
| -43% | -$767K | ﹤0.01% | 2474 |
|
|
2021
Q2 | $2.28M | Sell |
27,360
-28,331
| -51% | -$2.36M | ﹤0.01% | 1992 |
|
|
2021
Q1 | $4.27M | Buy |
55,691
+24,753
| +80% | +$1.9M | ﹤0.01% | 1437 |
|
|
2020
Q4 | $2.73M | Buy |
+30,938
| New | +$2.73M | ﹤0.01% | 1604 |
|